arrow
返回期刊详情
T

The Oncologist

IF
论文数237
被引数
期刊论文 237
发表时间
Utilizing Micro-RNA-371a-3p for Recurrence Prediction in Clinical Stage I Testicular Cancer利用Micro-RNA-371a-3p预测临床I期睾丸癌的复发
delete2026-07-11
delete0
deleteOAAI
deleteRichard S Matulewicz; Andrea Knezevic; Adam Levin; Fei Ye; Darren R Feldman; Samuel A Funt
delete分享
delete收藏
Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177–PSMA-617新型风险评分系统用于接受镥-177–PSMA-617治疗的患者中的转移性去势抵抗性前列腺癌
delete2026-07-11
delete0
deleteOAAI
deleteMargo B Gerke, MD; Angelo Marra, MPH; Michelle Jayaraj, BA; Ahmet Yildrim, MD; Akshay Bedmutha, MD; Jacqueline T Brown, MD; Bassel Nazha, MD; Jacob E Berchuck, MD; Ravi Bharat Parikh, MD; Shahid Ahmed, MD; Jordan Alana Ciuro, MD; Caitlin Hartman, FNP; Greta Russler McClintock, FNP; Sarah Caulfield, PharmD; Omer Kucuk, MD; Bradley Curtis Carthon, MD, PhD; David M Schuster, MD; Saima Muzahir, MD; Yuan Liu, PhD; Mehmet Asim Bilen, MD; null
delete分享
delete收藏
Optimizing Postoperative Prognostication in Duodenal Adenocarcinoma: A Multicenter Study with External Validation优化十二指肠腺癌术后预后预测:一项具有外部验证的多中心研究
delete2026-07-09
delete0
deleteOAAI
deleteZongting Gu, MD; Qifeng Xiao, MD; Xin Wu, MD; Chunhui Yuan, MD; Xiaolong Tang, MD; Fanbin Meng, MD; Dong Wang, MD; Ren Lang, MD; Kaiqing Guo, MD; Xiaodong Tian, MD; Yu Zhang, MD; Enhong Zhao, MD; Zhenzhou Wu, MD; Jingyong Xu, MD; Ying Xing, MD; Feng Cao, MD; Chengfeng Wang, MD; Jianwei Zhang, MD; null
delete分享
delete收藏
Target trial emulation studies in oncology: a comprehensive analysis肿瘤学中的目标试验模拟研究:一项综合分析
delete2026-07-07
delete0
deleteOAAI
deleteChenfeng Tan; Zelei Dai; Renjie Zhao; Kefan Li; Bingran Zhang; Ying Wang; Nian Li; Lei Liu; Yonggang Zhang; null
delete分享
delete收藏
Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population恶性周围神经鞘瘤在丹麦神经纤维瘤病1型人群中的患病率、治疗和生存情况
delete2026-07-03
delete0
deleteOAAI
deleteNinna Aggerholm-Pedersen; Mette Møller Handrup; Stine Bogestofte Thomassen; Bodil Engelmann; Katja Maretty Kongstad; Maria Vad Jakobsen; Thomas Baad-Hansen; Stense Farholt; David Thomas; Cecilie Ejerskov
delete分享
delete收藏
Molecular Tumor Board–Guided Osimertinib Therapy in EGFR L858R/Q701L–Mutant Lung Adenocarcinoma Supported by Functional Validation分子肿瘤委员会指导下的奥希替尼治疗EGFR L858R/Q701L突变型肺腺癌,并通过功能验证支持
delete2026-07-02
delete0
deleteOAAI
deleteCorinna Albers-Leischner; Matthias Ritgen; Finn-Ole Paulsen; Benjamin Schmidt; Nikolas von Bubnoff; Sivahari Prasad Gorantla; Anne Letsch; Melanie Janning; Sonja Loges; Carsten Bokemeyer; Maximilian Christopeit
delete分享
delete收藏
Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3OBI-3424的II期剂量扩展试验,OBI-3424是一种DNA烷化前药,用于表达AKR1C3的晚期实体瘤患者
delete2026-07-02
delete0
deleteOAAI
deleteApostolia Maria Tsimberidou; Claire Verschraegen; Darren Sigal; Heinz-Josef Lenz; Howard Hochster; Mehmet A Baysal; Abhijit Chakraborty; Ingly Lee; Koenuel Ristoski; Dong Xu
delete分享
delete收藏
Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors生殖细胞肿瘤中体细胞转化的生物学差异和结局
delete2026-06-30
delete0
deleteOAAI
deleteZachariah Thomas, MBBS; Andrew C Johns, MD; Michael Glover, MD; Emanuele Crupi, MD; Yago L Nieto, MD, PhD; John F Ward, MD, FACS; Jose A Karam, MD, FACS; Wayne L Hofstetter, MD; Monica Desai, MD; Seungtaek L Choi, MD; Amishi Y Shah, MD; John Lin, MD, MSHP; Mohammad Jad Moussa, MD; Cindy Y Jiang; Omar Alhalabi, MD; Matthew T Campbell, MD, MS; null
delete分享
delete收藏
Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid TumorsOBI-999剂量扩展研究,一种靶向Globo H的抗体药物偶联物,在晚期实体瘤患者中的应用
delete2026-06-29
delete0
deleteOAAI
deleteApostolia Maria Tsimberidou, MD, PhD; Darren Sigal, MD; Anna Varghese, MD; Daniel Vaena, MD; Li-Yuan Bai, MD, PhD; Ming-Huang Chen, MD, PhD; Chun-Nan Yeh, MD; Chia-Jui Yen, MD; Mehmet A Baysal, MD; Abhijit Chakraborty, PhD; Ingly Lee, MS; Chi-Sheng Shia, PhD; Konul Ristoski, MD; Dong Xu, PhD
delete分享
delete收藏
Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial脂质体伊立替康联合5-氟尿嘧啶和奥沙利铂(NALIRIFOX)在新辅助治疗胰腺腺癌中的应用:NEO-Nal-IRI试验
delete2026-06-29
delete0
deleteOAAI
deleteThomas J George; Tuo Lin; Ibrahim Nassour; Sherise C Rogers; Tim Jang; Ilyas Sahin; Brian H Ramnaraign; Jesus Fabregas; Kathryn Hitchcock; Gonghao Liu; Karen B Russell; Anita A Turk; Omar Kayaleh; Z Hugh Fan; David L DeRemer; Ryan M Thomas; Ji-Hyun Lee; Steven J Hughes
delete分享
delete收藏
Patient, Care Partner, and Oncologist Perspectives on Clinically Important Survival Thresholds After Considering Time Toxicity in Advanced Cancer患者、护理伙伴和肿瘤学家对在考虑时间毒性后晚期癌症临床重要生存阈值的不同看法
delete2026-06-27
delete0
deleteOAAI
deleteArjun Gupta, MD; Kendall Lin, BS; Rick J Jansen, PhD; Samuel X Stevens, MBBS; Manju George, MVSc PhD; Allison Breininger, MA; Christopher M Booth, MD; Helen M Parsons, PhD, MPH; Jeanette Y Ziegenfuss, PhD; Rachel I Vogel, PhD; Anne H Blaes, MD, MS
delete分享
delete收藏
Phase IB/II study of alpelisib combined with paclitaxel in patients with PIK3CA-altered metastatic or recurrent gastric cancer阿尔佩利斯ib联合紫杉醇在PIK3CA突变型转移性或复发性胃癌患者中的 Ib/II 期研究
delete2026-06-26
delete0
deleteOAAI
deleteJi-Won Kim; Seonghae Yoon; Min-Hee Ryu; Sung Hee Lim; Seung Tae Kim; Tae-Yong Kim; Hye Sook Han; Minkyu Jung; Jin Won Kim; Jee Hyun Kim; Dae Young Zang; Keun-Wook Lee; null
delete分享
delete收藏